Síndrome de Sjögren primario

Diana Pizarro Méndez

Resumen


Es probable que en el futuro, el estudio de varios factores de riesgo genéticos constituya una herramienta diagnóstica, o bien predictiva, que permita una clasificación más certera de los pacientes con SSp. Lamentablemente, no hay suficiente evidencia científica que valide los tratamientos utilizados hasta la fecha, y que puedan ser utilizados en una gran parte de la población afectada, debido a las diferencias en manifestaciones clínicas del síndrome. Es de importancia estudiar y recordar las manifestaciones clínicas del SSp, así como las herramientas disponibles para su diagnóstico; ya que es una enfermedad de gran importancia clínica y que está subdiagnosticada en nuestra población adulta mayor.

Texto completo:

PDF

Referencias


Abdulahad W., Kroese F., Vissink A., Bootsma H. Immune regulation and B-cell depletion therapy in patients with primary Sjögren’s syndrome, Journal of Autoimmunity. 2012; 39 (1–2): 103-111.

Alunno A., Carubbi F., Bartoloni F., Bistoni O., Caterbi S., Cipriani P., et al. Unmasking the pathogenic role of IL-17 axis in primary Sjögren’s syndrome: A new era for therapeutic targeting? Autoimmunity Reviews, 2014; 13 (12): 1167-1173.

Baldini C., Talarico R., Tzioufas A., Bombardieri S. Classification criteria for Sjogren’s syndrome: A critical review, Journal of Autoimmunity, 2012; 39 (1–2): 9-14.

Barrera M., Bahamondes V., Sepúlveda D., Quest A., Castro I., Cortés J., et al. Sjögren’s syndrome and the epithelial target: A comprehensive review, Journal of Autoimmunity. 2013; 42: 7-18.

Burbelo P., Ambatipudi K., Alevizos I. Genome-wide association studies in Sjögren’s syndrome: What do the genes tell us about disease pathogenesis? Autoimmunity Reviews. 2014; 13 (7): 756-761.

Castro I., Sepúlveda D., Cortés J., Quest A., Barrera M., Bahamondes V., et al. Oral dryness in Sjögren’s syndrome patients. Not just a question of water, Autoimmunity Reviews, 2013; 12 (5): 567-574.

Colafrancesco S., Perricone C., Priori R., Valesini G., Shoenfeld Y. Sjögren’s syndrome: Another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA), Journal of Autoimmunity. 2014; 51: 10-16.

Cornec D., Jamin C., Pers J. Sjögren’s syndrome: Where do we stand, and where shall we go?, Journal of Autoimmunity, 2014; 51: 109-114.

Guellec D., Cornec D., Jousse- Joulin S., Marhadour T., Marcorelles P., Pers J., et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren’s syndrome: A systematic review, Autoimmunity Reviews, 2013; 12 (3): 416-420.

Hernández G., Leal G., Michel M. The meaning of anti-Ro and anti La antibodies in primary Sjögren’s syndrome, Autoimmunity Reviews. 2011; 10, (3): 123-125.

Ice J., Li H., Adrianto I., Chee Lin P., Kelly J., Montgomery C., et al. Genetics of Sjögren’s syndrome in the genome-wide association era, Journal of Autoimmunity. 2012; 39 (1–2): 57-63.

Kivity S., Arango M., Ehrenfeld M., Tehori O., Shoenfeld Y., Anaya J., et al. Infection and autoimmunity in Sjogren’s syndrome: A clinical study and comprehensive review, Journal of Autoimmunity. 2014; 51: 17-22.

Kramer J. Early events in Sjögren’s Syndrome pathogenesis: The importance of innate immunity in disease initiation. Cytokine 2014; 67 (2): 92-101.

Kyriakidis N., Kapsogeorgou E., Tzioufas A. A comprehensive review of autoantibodies in primary Sjögren’s syndrome: Clinical phenotypes and regulatory mechanisms, Journal of Autoimmunity. 2014; 51: 67-74.

Pavlakis P., Alexopoulos H., Kosmidis M., Mamali I., Moutsopoulos H., Tzioufas A., et al. Peripheral neuropathies in Sjögren’s syndrome: A critical update on clinical features and pathogenetic mechanisms, Journal of Autoimmunity. 2012; 39 (1–2): 27-33.

Seror R., Theander E., Bootsma H., Bowman S., Tzioufas A., Gottenberg J., et al. Outcome measures for primary Sjögren’s syndrome: A comprehensive review, Journal of Autoimmunity. 2014; 51: 51-56.

Tobón G., Pers J., Youinou P., Saraux S. B cell-targeted therapies in Sjögren’s syndrome, Autoimmunity Reviews, 2010; 9 (4): 224-228.

Yao Y., Liu Z., Jallal B., Shen N., Rönnblom L. Type I interferons in Sjögren’s syndrome, Autoimmunity Reviews. 2013; 12 (5): 558-566.


Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2018 Revista Médica de Costa Rica y Centroamérica



Dirección OAI:

http://www.revistamedicacr.com/index.php/rmcr/oai/

Todos los derechos reservados. Se prohibe la reproducción total o parcial.

Revista Médica de Costa Rica 2021. ISSN:22155201